CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- 4 Open-market sale CMO, Hematology sold 3,000 shares at $139.58 ($418,750)
- 4 Gift Director gave 89,999 shares (gift)
- 4 Gift Director gave 9,414 shares (gift)
- 4 Open-market sale Director sold 5,000 shares at an average $124.30 ($621,490)
- 4 Open-market sale CMO, Immuno-oncology sold 40,000 shares at an average $120.20 ($4,808,089)
- 4 Open-market sale CMO, Hematology sold 2,911 shares at $174.60 ($508,247)
- 4 Open-market sale Director sold 2,000 shares at $179.00 ($358,000)
- 4 Open-market sale CMO, Immuno-oncology sold 5,769 shares at an average $169.12 ($975,666)
- 4 Open-market sale Director sold 3,449 shares at an average $158.77 ($547,591)
- 4 Open-market buy Director bought 5,814,100 shares at $108.00 ($627,922,800)
- 4 Open-market sale Chief Executive Officer sold 2,550 shares at $164.12 ($418,497)
- 4 Grant or award Chief Executive Officer acquired 188,266 shares (grant or award)
- 4 Grant or award CFO & Chief Strategy Officer acquired 52,338 shares (grant or award)
- 4 Grant or award CMO, Hematology acquired 44,564 shares (grant or award)
- 4 Grant or award CMO, Immuno-oncology acquired 44,564 shares (grant or award)
- 4 Grant or award Director acquired 94,133 shares (grant or award)
- 4 Grant or award Director acquired 9,290 shares (grant or award)
- 4 Grant or award Director acquired 9,290 shares (grant or award)
- 4 Grant or award Director acquired 9,290 shares (grant or award)
- 4 Grant or award Director acquired 9,290 shares (grant or award)
Page 24 of 29 · 580 filings